CRISIL reaffirms UFLEX at AA
UFLEX (UFLEX) said CRISIL has reaffirmed its credit rating at AA, covering facilities or instruments of about ₹4,600 crore. The company is valued at about ₹4,466 crore.
What happened
UFLEX (UFLEX) told the exchanges on 20 October 2026 at 11:53 AM that CRISIL has reaffirmed its credit rating at AA, covering facilities or instruments of about ₹4,600 crore.
Company snapshot
UFLEX is a small-cap company, with a market value of about ₹4,466 crore.
The stock last traded at ₹618.5, against a 52-week range of ₹330–₹723.5 (14.5% below the high).
Before this filing the shares had moved −4.2% over the month and +41.4% over three months. Average daily turnover over the last 20 sessions was about ₹7.19 crore.
Promoters held 44.58% at the end of Q1 FY27. Foreign institutions owned 10.03% and domestic institutions 0.60%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 3,901 | 58 | 8.03 |
| Q2 FY26 | 3,832 | 26.9 | 3.73 |
| Q3 FY26 | 3,612 | 36.1 | 5.01 |
| Q4 FY26 | 4,056 | 196 | 27.15 |
| Q1 FY27 | 5,366 | 423.1 | 58.62 |
What history shows
This is not the company's first credit rating disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.3% on average the next trading day and was up 0.9% on average after five days (2 filings with price data).
Market-wide, 1,317 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 9 Oct 2026 | Intimation in respect of affirmation of Credit Ratings under the… | +2.7% | — |
| 7 Aug 2026 | Credit rating | +1.8% | +0.9% |
What to watch
- Whether other agencies take a similar view on the company's credit.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.